Mutant screens have proven powerful for genetic dissection of a myriad of biological processes, but subsequent identification and isolation of the causative mutations are usually complex and time consuming. We have made the process easier by establishing a novel strategy that employs whole-genome sequencing to simultaneously map and identify mutations without the need for any prior genetic mapping.
T HE challenges posed by the identification of a causal mutation in a mutant of interest have in effect restricted the use of forward genetics to those organisms benefiting from a solid genetic toolbox. Whole-genome sequencing (WGS) is promising to revolutionize the way phenotypic traits are assigned to genes. However, current strategies to identify causal mutations using WGS require first the identification of an approximate genomic location containing the mutation of interest Smith et al. 2008; Srivatsan et al. 2008; Blumenstiel et al. 2009; Irvine et al. 2009 ). This is because genomes contain many natural sequence variations Sarin et al. 2010) , which, along with mutagen-induced ones, complicate the identification of the causal mutation when an approximate genomic location has not been previously identified. Mapping has previously been achieved with time-consuming and laborious techniques that, in addition, rely on an organism's single-nucleotide polymorphism (SNP) map and established variant strains. For example, traditional SNP-based mapping (Wicks et al. 2001; Davis et al. 2005) has previously been used in Caenorhabditis elegans to narrow down the genomic region containing the mutation of interest, prior to conducting WGS . In Arabidopsis, simultaneous SNP mapping and mutation identification has been achieved with WGS, but this requires the generation of a mapping population of up to 500 F 2 progeny to identify only one allele (Schneeberger et al. 2009 ). This is a challenging prospect for many model systems. Indeed, if the mutant phenotype is subtle, the isolation of such numbers of recombinants is very tedious. Furthermore, it is not applicable in those organisms where a mapping population cannot be generated, simply because of a lack of intercrossable variants or because of life cycles (parasitic organisms, for example) that would make it extremely difficult to follow and isolate many recombinant individuals.
Here, we describe a strategy to simultaneously and rapidly locate and identify multiple mutations from a mutagenesis screen with WGS that circumvents these limitations. This powerful and straightforward method directly uses mutagen-induced nucleotide changes that are linked to the causal mutation to identify its specific genomic location, thus negating the construction of genetic mapping populations and subsequent mapping.
Treatment of organisms with a chemical mutagen induces nucleotide changes throughout the genome. Following mutagenesis, backcrossing or outcrossing of the mutagenized organism to unmutagenized counterparts is performed to eliminate mutagen-induced mutations ( Figure 1A ; supporting information, File S2). The phenotype-causing mutation remains as only backcrossed individuals showing the phenotype of interest are retained. In addition, mutagen-induced nucleotide changes that are genetically linked to the causal mutation and physically surround it on the chromosome Supporting information is available online at http:/ /www.genetics.org/ cgi/content/full/genetics.110.119230/DC1. 1 will remain, in contrast to unlinked nucleotide changes ( Figure 1A ). As a result of this genetic linkage, a highdensity cluster of typical mutagen-induced variants is visualized from sequence data obtained by WGS, which is positioned around the causal mutation. By locating such high-density regions, one maps the approximate genomic location of the causal mutation and subsequently identifies the affected gene within this region.
As a proof-of-principle, we simultaneously mapped and sequenced the causal mutations of multiple C. elegans mutants isolated from an EMS mutagenesis screen using this strategy. The mutagenesis screen itself was undertaken to identify genes that controlled the reprogramming of a single cell called Y into another cell called PDA during C. elegans development ( Jarriault et al. 2008) . After EMS treatment, three distinct mutant alleles (fp6, fp9, and fp12) were backcrossed to the original unmutagenized strain 4-6X. It is important to note that a backcrossing or outcrossing step is necessary for the analysis of mutants obtained from all mutagenesis screens, irrespective of the type of mutant identification strategy used or the type of mutagen or organism used (and, as such, does not represent an extra step introduced by our method). The mutants then underwent WGS side-by-side (Table S1, Table S2 , Figure S1 , and File S2). After alignment to the wild-type N2 reference genome using MAQgene software ), the sequencing data obtained for each mutant were compared, and we subtracted common nucleotide variants that were shared between at least two of our three mutants (File S1). These shared variants, which are very unlikely to be either the causal Figure 1 .-Mapping mutations on the basis of density of mutagen-induced DNA damage across the genome. (A) Visual representation of our WGS cloning strategy. Mutagen treatment induces point mutations throughout the genome (red asterisks). Backcrossing to the original unmutated parent strain removes much of the mutagen-induced nucleotide changes except for the causal mutation (green asterisk) and those genetically linked to it. WGS sequencing can be used to detect canonical mutageninduced point mutations, thus revealing a physical position for the causal mutation. Shared background variants (yellow crosses) are filtered out from WGS data by comparing the sequences of mutants sequenced side-by-side, revealing a high-density variant cluster in only one genomic region. Importantly, genomic sequences of mutants derived from the same starting strain must be compared, to allow subtraction of nucleotide variants that are common to this particular strain, through sequence comparison. (B) Physical map of total nucleotide variations per megabase across the genome compared to the wild-type reference genome for each mutant ( fp6, fp9, and fp12) after WGS. (C) After sequence quality filtering, subtraction of common variants between the 3 mutants, and filtering out noncanonical EMS nucleotide changes, high-density variant peaks are obtained in one genomic location for each mutant (red boxes). Steps 1 and 3 are essential for clear visualization of the high-density peaks whereas step 2 improves visualization. (D) Close-up of variants on chromosome III for fp6. Within this peak we identified only 6 candidate mutations that could potentially affect a protein sequence. We confirmed that the missense mutation in egl-5 was the causal mutation ( Figure S2 ). For fp9 and fp12 we identified only 10 (9 missense and 1 39-UTR) and 4 (2 premature stop and 2 missense) candidate mutations, respectively, within each mutant's EMS-based mapped region. Thus, our method consistently allowed precise mapping in 3 different mutants to a region small enough to contain only a handful of candidate mutations. mutation or EMS-induced mutations from the screen itself, represent strain differences between the N2 used to generate the reference genome and the PS3662 strain used here for mutagenesis. Note that this step eliminated 2000 point mutations as potential candidates for our causal mutation. This result strongly emphasizes the advantage of conducting WGS on two or more mutants side-by-side, as reference genomes may contain many nucleotide variations when compared to organisms sequenced from the laboratory Sarin et al. 2010 ; this study) and as such would confound mutation identification.
To identify EMS-induced changes linked to the causal mutation and expose its location, we looked only at variants that matched the canonical EMS-induced G/C . A/T transitions (Drake and Baltz 1976) , revealing localized peaks of high-density variation on a single chromosome for each mutant ( Figure 1 , B and C). These peaks correspond to regions of high mutageninduced damage that were not removed during backcrossing and therefore are most likely genetically linked to the causal mutation. We therefore focused our attention on these physical regions to identify candidate mutations within them. We localized fp6 to a 4.29-Mb region on chromosome III, fp9 to a 7.11-Mb region on chromosome X, and fp12 to a 1.28-Mb region on a different part of chromosome X ( Figure 1C) .
As a proof of principle, we further examined the nucleotide changes present in the interval to which fp6 was linked. Taking into consideration all variant types (point mutations and indels), we identified only six candidate mutations that potentially affected a gene's function ( Figure 1D and Table S3 ). One of these, affecting the egl-5/hox gene, lies almost perfectly in the middle of the predicted EMS-based mapped region. We confirmed the existence of the mutation in egl-5 by manual resequencing. Both egl-5 targeted RNAi and noncomplementation with the egl-5(n945) null allele confirmed that fp6 affected egl-5 and caused the Y-to-PDA reprogramming defect ( Figure S2 ). fp9 and fp12 each map to distinct regions on chromosome X that also contain only a handful of candidate mutations (10 and 4, respectively) ( Figure 1C ). Thus, our method consistently allowed precise mapping in 3 different mutants to a region small enough to contain only a handful of candidate mutations and subsequent identification of the causal mutation.
We calculated that comparison of WGS data for only two mutants of the same mutagenesis screen is sufficient to localize and sequence the causal mutation (Table 1,  Table S4 ). Thirteen times sequence coverage has been found to be sufficient to identify a mutation in a pre-SNP mapped C. elegans mutant ). Here, we tested the sequence coverage necessary to perform simultaneous mapping and mutant identification using our strategy and found that 133 was more than enough (Table 1, Table S4 ). In addition, by performing longer reads and/or paired-end sequencing, our method can be scaled up to bigger genomes or allow multiple mutant sequencing on each flow cell lane [for, e.g., using multiplex WGS (Cronn et al. 2008) ]. Furthermore, because direct sequence comparison is ultimately made between two mutants sequenced side-by-side, the quality of an organism's reference genome (which is We found that all of the minimal requirements tested here were more than adequate to use our mapping strategy. Therefore, it is possible that fewer backcrosses and less sequencing coverage may suffice than is shown here. For example, for genomes with a similar size to C. elegans (100 Mb), this method can easily be scaled up by sequencing eight mutants per flow cell. As for any WGS experiments, total cost depends on genome size.
used only for alignment purposes) does not have a bearing on the mapping or mutant identification outcome. Moreover, recent advances in de novo alignment of short reads generated from next generation sequencing platforms (Li et al. 2010; Nowrousian et al. 2010; Webb and Rosenthal 2010; Young et al. 2010) suggest that a reference genome may not even be required to perform mutagen-based mapping and mutant identification with WGS. We predict that technical advances in these areas will make it possible to perform mutagenesis screens on any nonsequenced and genetically uncharacterized organism and use our strategy to quickly identify the causal mutation of an interesting mutant.
By eliminating any prior work except for back/ outcrossing, a necessary step for any mutant characterization, our simple and quick strategy provides a significant saving of time and labor as the time needed to map and identify a candidate causal mutation is trimmed down to the sequencing time (currently 7 days) and sequence analysis time (,1 day, see Table 1 ). In addition, our strategy allows simultaneous discovery of multiple mutant alleles from a mutagenesis screen without any mapping population generation, thus making it conceptually easy to apply to many species. Indeed, our strategy is applicable to any vertebrate or invertebrate organism subjected to mutagenesis and will be particularly useful for those organisms where traditional genetic mapping is tedious and long. The only requirement to carry on this mutant identification strategy is that the organism be amenable to back/outcrossing. Perhaps most importantly, the strategy does not use species-specific SNPs to map the mutation, thus avoiding many constraints of previous methods. Thus, the spiraling-down cost of next generation sequencing technology and the establishment of our strategy open the exciting prospects of performing creative mutagenesis screens in a wide range of organisms. FIGURE S1.-Distribution of deep sequencing coverage. For each mutant (fp6, fp9, and fp12), average coverage of each nucleotide per MB is shown across all chromosomes for combined 2-lanes paired-end data. The large peak at the very end of chromosome I may represent a highly repetitive element aligned to only a single location (within 1MB). The large peak on chromosome II maps to the location of the cog-1 gene. This most likely corresponds to sequencing of the cog-1::gfp transgene integrated into the background strain PS3662. Subsequent alignment to the native cog-1 sequence would thus over-represent coverage in this region.
FIGURE S2.-Confirmation of egl-5(fp6) mutation. (A)
Sanger sequencing revealed a C to T substitution in the same position of egl-5 exon 4 as did WGS, resulting in a Threonine to Isoleucine amino acid change. The affected amino acid is a conserved residue in the highly conserved Hox domain of EGL-5. (B) fp6 and the null allele egl-5(n945) did not complement for the Y-to-PDA defective phenotype confirming that fp6 affects the egl-5 gene and that it is the causal mutation for the "no PDA" phenotype. Both fp6 and egl-5(n945) are recessive. Homozygotes for fp6 and egl-5(n945) are approximately 100% penetrant for the defective Y-to-PDA phenotype. Hermaphrodite progeny from the cross between fp6/+ and egl-5(n945) were identified by the presence of cog-1::gfp transgene initially carried by fp6/+ males. Three separate crosses yielded the same result. (C) Lowering the activity of egl-5 by RNAi results in a "no PDA" phenotype, which phenocopies the fp6 mutants. n =164 for (B) and n = 165 for (C). Control animals were fed an empty RNAi vector. n = total number of animals scored.
FILE S1

Shared variants found in fp6, fp9 and fp12
File S1 is available for download as an Excel file at http://www.genetics.org/cgi/content/full/genetics.110.119230/DC1.
Our results and others suggest that mutations accumulation is significant, at least in C. elegans, and that the N2 derived strains that exist in different laboratories can exhibit a very different genomic background. As the identity of these variants may be useful to the C. elegans community for WGS analysis simplification (i.e. to filter out and discount these variations as possible candidate mutations), we provide these SNPs as a supporting dataset.
FILE S2
Supporting Methods
Preparation of mutants: C. elegans were cultured using standard methods (BRENNER 1974) . We conducted an EMS mutagenesis screen in N2 nematodes carrying a cog-1::gfp transgene (PS3662 strain) that localizes GFP expression to the PDA neuron and thus allows us to select mutants that lack PDA (J. Richard, S.Z. , N. Fischer, V. Pavet, N. Vaucamps & S.J., submitted). Three mutants belonging to 3 distinct complementation groups were chosen and backcrossed to the original PS3662 strain (6X for fp6 and fp12, and 4X for fp9) . We recommand that a mutagen introducing typical changes at a high frequency be used, as this facilitates the subsequent causal mutation identification. For example, damage induced by ethane methyl sulfonate (EMS) or N-ethyl-N-nitrosourea (ENU), two commonly used chemical mutagens, may be detected by the canonical nucleotide transitions they cause. Although the type of mutagen used depends on the organism to be mutagenised, one aspect that impacts on this strategy, alongside a predictable mutation type, is the mutation rate of the mutagen. In the centre of the linked regions for each mutant we sequenced, we observed G/C > A/T nucleotide changes at a frequency of 7-8 per Mb. This would correspond to a frequency of 1 mutation in every ~125 000-143 000 base pairs from a 50 mM EMS dose. In the un-linked regions of the genome, where backcrossing would have removed most, if not all, of the EMS-induced nucleotide changes, we observed between 0-2 typical EMS-induced changes per Mb. Even though a small proportion of these G/C > A/T nucleotide changes may have occurred spontaneously through genetic drift, this particular mutation load presented us with very obvious high-density variation peaks in which to concentrate our search for the causal mutation. However, a lower mutation rate may also suffice. ENU has been reported to induce 0.5-1 mutation in every 100 000 nucleotides in mice (BEIER 2000) and would thus be appropriate for use with our strategy.
Genetic drift, mixed-origin reference genome and backcrossing: A number of studies have suggested that natural genomic variations occur between strains of the same species, especially in laboratory conditions. For example, strains of C. elegans continuously grown for more than 2 years have been suggested to accumulate as many mutations as after EMS treatment . The use of WGS has started to provide extensive molecular evidence of the existence of hundreds to thousands of differential variants between the N2 sequenced reference genome and N2 derived laboratory strains has been described . The existence of mutation accumulation and genetic drift represents a challenge to mutation identification using strategies that involve comparison of the genome sequence of mutants to a reference genome, considering that, in addition to mutagenesis, the mutants may have accumulated other new variants spontaneously. In addition, a reference genome can have been made from an assembly of a number of different individuals (as is the case for the ongoing Zebrafish genome [www.sanger.ac.uk/Projects/D_rerio]). However, genetic drift or a mixed-origin reference genome do not represent an issue for mutation identification using our strategy, as the mutant genomes are compared between each other for identification and removal of background variants. This strategy vastly increases the overall robustness of mutation identification by minimizing false-positive and falsenegative results caused by reference genome errors. We recommend backcrossing to the original strain that was subjected to mutagenesis. Doing so ensures that all mutant strains will share the same background variation, which can be subsequently subtracted. Outcrossing of the mutant strains to another wild-type isolate is also possible, but may yield more than one region of high density variation: one around the causal mutation and at least one around any other genomic locus that has to be kept in the mutant strain, such as the integration site of a reporter transgene. The number of high-density regions increases with the number of loci that need to be kept during outcrossing. We believe that the risk of having a mixed variants signature when another strain than the original strain is used to outcross is very low if outcrossing has been performed thoroughly (4X should be enough based on our experience of removing EMS-induced changes outside of linked genomic regions). Depending on the speed of genetic drift within a given species, backcrossing mutants from a mutagenesis screen in a timely manner with the original un-mutagenised strain will minimize drift. If backcrossing cannot be performed directly after the screen and if, like C. elegans, populations can be frozen and retrieved at a latter time, we recommand to keep a frozen aliquot of the original strain used for the screen and freeze the mutants retrieved directly after the screen. We also recommand to backcross multiple mutants in parallel if they are to be sequenced together.
Preparation of genomic DNA and genome sequencing: Genomic DNA was prepared from populations of each mutant using the Gentra Puregene Kit (Qiagen). 10 mg of genomic DNA was fragmented by nebulisation (according to Illumina instructions) to obtain fragments in the range of 500bp in size. Sequencing libraries were made according to the Illumina protocol. The three paired-end libraries were sequenced at the IGBMC sequencing platform on the Illumina GAII as 57-bp paired end reads, following the manufacturer's protocols. Each mutant was sequenced on two flow cell lanes producing coverage of 52.2-55.3X for the 3 mutants across the genome (SI table 2). Image analysis and base calling was performed with Illumina Pipeline version 1.6 with default parameters.
Analysis software: Sequences were mapped to E. coli strain 536 using Bowtie (LANGMEAD et al. 2009 ) version 0.12.0. Subsequently, short read alignment and variant calling were performed using MAQGene software ) revision 33. Mutant reads were aligned against the N2 reference genome (wormbase.org version WS201). MAQGene was used with default parameters except for the max distance between two paired reads which was set to 1000. Comparison of called variants between mutants was performed with custom Perl scripts. Before filtering out common nucleotide variants between our mutants we observed between 2 336 and 2 457 single-nucleotide differences between our mutants and the N2 reference genome. After this step, the number of variations was dramatically reduced to between 415 to 488 nucleotides, thus eliminating approximately 2 000 point mutations as potential candidates for our causal mutation. This result strongly emphasizes the advantage of conducting WGS on two or more mutants side-by-side, as reference genomes may contain many nucleotide variations when compared to organisms sequenced from the laboratory, and as such would confound mutation identification. Alternatively, one may conduct WGS on the original starting strain used for mutagenesis, which could be used to eliminate strain specific variations. However, in the interests of reducing costs it would be more advantageous to directly sequence multiple mutants of the same background instead. Quality filtering involved selecting only those variants with a MAQgene mapping score of 63 with 0 wild-type reads. EMS may cause other genetic changes such as small insertions or deletions (indels); however, for mapping purposes, we concentrated on the most typical EMSinduced change, as these were sufficient to identify a region containing the causal mutation. After the genomic region is identified quality filtering may be removed to reveal all variants (of all quality) detected within the mapped region, thus avoiding false negatives. In our experience, an EMS-induced variant linkage region is still discernable without firstly performing quality filtering suggesting that this step is not absolutely required for our strategy. a N2 wild-type genome contains ~36% GC content. b Number of clusters are shown after being purity filtered during Illumina pipeline. c High quality variants (MAQgene mapping score of 63 with 0 wild-type reads) shared in at least 2 of three mutants sequenced. We found that a total of 1477 high quality variants were identified to be common in at least 2 out of the 3 mutants. The common variants from our backcrossed mutants represent SNPs present in our starting strain (PS3662). Note that these numbers highlight how different our starting strain is in terms of variants, from the reference genome. This might be also true for many strains made in the N2 background, a fact that will be confirmed with additional sequencing of other backgrounds. a Average coverage is calculated by the mean number of times every nucleotide of the genome is sequenced. Distribution of coverage for 2-lanes paired sequencing is shown in Figure S1 . C. elegans genomes size is ~100 Mb. The variant in C08C3.1 (egl-5) (bold) was confirmed to be the causal mutation (see Figure S2 ). Importantly, we not only assessed canonical EMS induced nucleotide changes within the mapped region, but also took into consideration any other atypical EMS-inducible mutation that could have caused the Y-to-PDA defective phenotype (e.g. indels). However, no other types of mutations were found to affect gene products (data not shown).
